Novavax, Inc. (NVAX)
9.06
-0.29
(-3.10%)
USD |
NASDAQ |
May 15, 16:00
9.00
-0.06
(-0.66%)
After-Hours: 20:00
Novavax Market Cap : 1.490B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 19.46B |
| Merck & Co., Inc. | 275.09B |
| Pfizer Inc. | 144.37B |
| AbbVie, Inc. | 371.72B |
| Intellia Therapeutics, Inc. | 1.910B |
Market Cap Related Metrics
| PS Ratio | 2.537 |
| Price | 9.06 |
| Earnings Yield | -6.59% |
| Operating PE Ratio | 40.65 |
| Normalized PE Ratio | 1176.62 |